(Q34960365)

5 August 2017

1 reference

title

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications (English)

1 reference

5 August 2017

0 references

1 reference

0 references

1

Jean-Luc Cracowski

1 reference

5 August 2017

Thierry Durand

2

1 reference

PubMed ID

12377577

5 August 2017

Germain Bessard

series ordinal

3

1 reference

5 August 2017

1 August 2002

1 reference

Trends in Pharmacological Sciences

5 August 2017

1 reference

5 August 2017

23

1 reference

5 August 2017

360-366

1 reference

5 August 2017

8

1 reference

Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA‐reactive materials from prostaglandin‐like endoperoxides

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Isoprostanes: an overview and putative roles in pulmonary pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Vascular biology of the isoprostanes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Characterization of the effects of isoprostanes on platelet aggregation in human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Are endothelium-derived hyperpolarizing and contracting factors isoprostanes?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Metabolism of 8-iso-prostaglandin F2alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Response of rat thoracic aorta to F(2)-isoprostane metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

IPF2alpha-I: an index of lipid peroxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Urinary isoprostane excretion is not confounded by the lipid content of the diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Greater oxidative stress in healthy young men compared with premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

F2-isoprostane excretion rate and diurnal variation in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Modulation of oxidant stress in vivo in chronic cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increased lipid peroxidation in patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Alcohol-induced generation of lipid peroxidation products in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Smoking and oxidant stress: assay of isoprostane in human urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Oxidant stress in sled dogs subjected to repetitive endurance exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Oxidative stress in athletes during extreme endurance exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increased urinary F2-isoprostanes in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Increased urinary F2-isoprostane excretion in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

In vivo lipid peroxidation and platelet activation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Oxidative stress and platelet activation in homozygous homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Effects of vitamin E on lipid peroxidation in healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdeh

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902053-9

7 January 2021

10.1016/S0165-6147(02)02053-9

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12377577